KEY APPLICATION AREA

Genome & Epigenome Engineering

CRISPR/Cas9-based technologies have revolutionized the ability to engineer genetic sequences, gene expression networks, and the architecture of eukaryotic chromatin. Bioengineers at Rice University are harnessing these innovative capabilities to establish new genome and epigenome engineering approaches, illuminate the cellular mechanisms that safeguard the balance between health and disease, create patient-specific disease models, and develop cutting-edge therapeutics for single-gene disorders. This emerging field in bioengineering has the potential to significantly impact the future of life sciences, medicine, and the biotech industry.